IJGC Podcast

By BMJ GroupMedicine Health & Fitness

IJGC Podcast episodes

February 17, 2021 Reviewing the February Issue with Irina Tsibulak (Russian Version)
In this episode of the IJGC Podcast, Editorial Fellow Irina Tsibulak discusses the contents of the February issue in Russian.
12 min
February 11, 2021 Reviewing the February Issue with Anna Collins and Irina Tsibulak (English Version)
In this episode of the IJGC Podcast, Editorial Fellows Anna Collins and Irina Tsibulak discuss the contents of the February issue.
11 min
February 10, 2021 Physical Activity in Ovarian Cancer with Tamara Jones
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Tamara Jones to discuss physical activity in ovarian cancer. Dr. Jones is an Accredited Exercise Physiologist and PhD Candidate at Griffith University in Brisbane, Australia. Her research focus is on physical activity and exercise for people with cancer, in particular women with ovarian cancer, and the potentially positive impacts that physical activity and exercise may have on health outcomes.
21 min
February 02, 2021 Reviewing the January Issue with Florencia Noll (Spanish Version)
In this episode of the IJGC Podcast, Florencia Noll discusses the contents of the January issue of IJGC in Spanish.
19 min
February 01, 2021 Asbestos and Ovarian Cancer with Brian Slomovitz
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Brian Slomovitz to discuss asbestos and ovarian cancer. Dr. Slomovitzs is a Gynecologic Oncologist at Broward Health and Professor of Obstetrics and Gynecology at the Wertheim College of Medicine at Florida International University. He is an internationally recognized leader in gynecologic oncology clinical trials, specifically in immunotherapy and novel biomarker therapeutics. He also is a leader in sentinel lymph node detection for gynecologic malignancies.
Highlights
a. Asbestos comprises a family of small silicate fibers that are found in nature.
b. Asbestos is known to cause different types of cancer.
c. The causal association between asbestos and ovarian cancer is weak and inconsistent
d. Peritoneal mesothelioma is histologically similar to ovarian cancer and pathologic confirmation of diagnosis is required before causal assumptions are made
22 min
January 21, 2021 Ovarian Sex Cord Stromal Tumors with Mona El-Bahrawy
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Mona El-Bahrawyto discuss ovarian sex cord stromal tumors. Dr. El-Bahrawy is the lead author of “Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management" (https://ijgc.bmj.com/content/early/2021/01/07/ijgc-2020-002018), which is the Lead Article of IJGC’s February 2021 issue.
Dr. El-Bahrawy is Professor of Practice in Histopathology at Imperial College London, United Kingdom, and Professor of Pathology at the University of Alexandria, Egypt, and President of the Egyptian Committee for Pathology Training. She specializes in Gynaecological Surgical Pathology with special interest in Gynaecological Tumour Pathology.
Highlights:
- Ovarian sex cord stromal tumours are rare tumours that include benign and malignant variants.
- They are broadly classified into three categories, which include pure stromal tumors, pure sex cord tumors and mixed sex cord stromal tumors.
- Some tumor types harbor hallmark mutations, such as FOXL-2 mutations detected in the majority of adult granulosa cell tumors.
- Surgery is the main treatment modality for sex cord stromal tumors with some role for chemotherapy and hormonal therapy in advanced and recurrent tumors.
- There is potential for the identification of therapeutic targets and development of targeted therapy for these tumors.
27 min
January 21, 2021 Reviewing the January Issue with Sadie Jones and Navya Nair (English Version)
In this issue of the IJGC Podcast, Editorial Fellows Sadie Jones and Navya Nair discuss the contents of the January issue of IJGC.
15 min
January 14, 2021 Role of Trastuzumab in Uterine Papillary Serous Tumors with Amanda Fader
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Amanda Fader to discuss the role of trastuzumab in uterine papillary serous tumors. Dr. Fader is an Associate Professor of Gynecology and Obstetrics, Vice Chair of Gynecologic Surgical Operations and Director of the Center for Rare Gynecologic Cancers at Johns Hopkins School of Medicine. She is recognized internationally as a rare uterine and ovarian cancer expert and is an active member of NRG Oncology and helps develop and co-lead innovative gynecologic cancer clinical trials.
Highlights:
• Uterine serous carcinoma (USC) is a biologically aggressive endometrial cancer subtype that accounts for a disproportionately high rate of endometrial cancer-related deaths.
• 25-30% of women with both early and advanced stage USC will have HER2 positive tumors.
• Molecularly-based therapeutic approaches in USC are increasing.
• Trastuzumab, an anti-HER2 therapy, in combination with platinum/taxane-based chemotherapy improves survival outcomes for women with HER2 positive USC.
• A randomized, Phase III cooperative group study is planned to study additional anti-HER2 therapies in women with all stages of USC.
29 min
January 13, 2021 100th Podcast: Conversaciones con el Editor-en-Jefe
Para celebrar el podcast número 100 de la revista IJGC, el Comité Editorial propuso entrevistar en español a nuestro Editor-en-Jefe , el Dr. Pedro Ramírez. El Dr. Luis Chiva, Video-Editor de nuestra revista y miembro del consejo de ESGO realizó recientemente esta tarea. En este encuentro tan especial, el Dr. Pedro Ramirez nos cuenta muchos detalles que revelan cuales son los sueños que desearía que se hicieran realidad en un futuro proximo en nuestra revista
36 min
January 13, 2021 100th Podcast: Conversations with the Editor-in-Chief
In honor of the International Journal of Gynecological Cancer’s 100th podcast, IJGC’s Editor-in-Chief, Dr. Pedro Ramirez, is interviewed by IGCS President and IJGC Editorial Board Member Dr. Robert Coleman to discuss the experiences of the Editor-in-Chief.
25 min

About IJGC Podcast

From the publisher's feed

The International Journal of Gynecological Cancer (IJGC) podcast explores the latest research on detection, prevention, diagnosis, and treatment of gynecologic malignancies. Enjoy interviews with leading experts as they discuss novel and relevant topics in the field of gynecologic cancer.